12 August 2022

As the week draws to a close the big headline makers are GSK and Haleon which have both been mentioned in potential law suits relating to Zantac, the ulcer drug which proved so pivotal for GSK in the 1980/1990s.  Shares in both companies have fallen sharply with GSK dropping to £14, the lowest closing level for over 10 years.  Although the company has strenuously denied the allegations that the drug causes cancer the shares may be under a cloud for some time.

Featured Companies

The latest from The Trader

AIM MARKET

Appreciate Group – 28.5p

11 August 2022 - director dealing Chairman Guy Parsons has acquired 17,563 shares in the company at 28.4p.  Hardly a significant purchase but it continues...

Renold – 25p

4 August 2022 - acquisition The AIM-quoted supplier of industrial chains and related power transmission products has expanded its international operations with the acquisition of...

NWF Group – 224p

2 August 2022 - final results The AIM-listed specialist distributor of feed, fuel and food has announced its results for the year to 31 May...

Journeo – 120p

2 August 2022 - contract win and trading update The AIM- listed supplier of information systems and technical services to transport operators and local authorities...

MAIN MARKET

Qinetiq – 389.5p

10 August 2022 - acquisition The defence and technology group has announced that it has agreed to acquire the US group Avantus Federal LLC for...

Capita – 26.25p

8 August 2022 - interim results The interim results from outsourcing group Capita which covered the first half of 2022 have come in pretty much...

Devro – 186p

2 August 2022 - interim results This leading producer of collagen products for the food industry has released interim results for the six months to...

Capita – 29.5p

2 August 2022 - disposal The consulting and outsourcing group Capita has announced another disposal as it seeks to exit from its non-core businesses.  The...

Penny Stocks

Latest Newsletters